CHE vs PEN
Chemed Corp. vs Penumbra, Inc. — AI-powered side-by-side comparison
VS
PEN
Penumbra, Inc.
71
Buy
| Metric | CHE | PEN |
|---|
| AI Score |
71
|
71
|
| Price |
$524.92
|
$326.94
|
| P/E Ratio |
26.75×
|
79.96×
|
| ROE |
27.1%
|
12.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
30.4%
|
67.8%
|
| Debt / Equity |
0.40×
|
0.14×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
48.6
|
82.9
|
| Beta |
0.511
|
0.701
|
| Expected Upside |
+0.7%
|
+6.0%
|
AI Committee View
Current Innellis committee reasoning for CHE versus PEN.
The committee scores are tied.
CHE and PEN both score 71/100.
CHE Committee View
75% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
PEN Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- 2 consecutive earnings misses -- execution concerns — Growth
- RSI at 83 is in overbought territory — Technical